---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-24-000020"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2024-03-26T23:59:59+00:00"
generated_at: "2026-06-04T07:54:59.835050+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics regains Nasdaq MVLS compliance; listing continues

## Summary
- Nasdaq notified vTv Therapeutics on March 25, 2024 that it regained compliance with the $35M MVLS minimum.
- Common stock ticker VTVT will continue listing on the Nasdaq Capital Market.
- No further deficiency actions required; prior MVLS concern resolved.

## SEC filing metadata
- accession: 0001641489-24-000020
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2024-03-26T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148924000020/0001641489-24-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148924000020/vtvt-20240325.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-24-000020
- JSON: https://secwatch.observer/filing/0001641489-24-000020.json
- Plain text: https://secwatch.observer/filing/0001641489-24-000020.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.